| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,256,204 | 15,854,912 | 12,968,644 | | Cost of Revenue | 5,643,230 | 5,523,619 | 3,854,333 | | | Gross Profit | 8,612,974 | 10,331,292 | 9,114,311 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,036,593 | 3,495,389 | 3,132,935 | | Non Recurring |
-
|
-
|
-
| | Others | 2,509,110 | 538,623 | 992,580 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,067,271 | 6,297,281 | 4,988,796 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,067,271 | 6,297,281 | 4,988,796 | | Interest Expense | 2,678,676 | 2,897,628 | 2,157,607 | | Income Before Tax | 388,595 | 3,399,653 | 2,831,189 | | Income Tax Expense | 286,286 | 921,171 | 682,436 | | Minority Interest | 17,934 | (12,496) | (3,014) | | | | Net Income From Continuing Ops | 120,244 | 2,465,987 | 2,145,739 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 120,244 | 2,465,987 | 2,145,739 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $120,244 | $2,465,987 | $2,145,739 |
|
0.75% Nasdaq 
0.58 (1.70%) 
Income Statement
